Eli Lilly cuts cash prices for Zepbound weight-loss vials on LillyDirect, offering doses from $299 to $449 as demand for ...

LLY leans on tirzepatide and a deep late-stage pipeline to defend its obesity momentum as new rivals make rapid progress in ...

ReBoost Nasal Spray has been recalled nationwide after tests found mold and bacteria, prompting FDA warnings of possible ...

No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...

Tirzepatide, used in Mounjaro and Zepbound, can produce dramatic weight loss and improvements in blood pressure, cholesterol ...

Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to ...

With no evidence base to draw upon, clinicians are sharing strategies to help patients stop taking the new weight-loss drugs ...

USA: Researchers have found in a new study that stopping tirzepatide (Zepbound) often leads to weight regain, along with the ...

The company said some patients had dropped out of the trial because they felt they were losing too much weight.

They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.

Citi Annual Global Healthcare Conference 2025 December 2, 2025 10:30 AM ESTCompany ParticipantsIlya Yuffa - Executive VP ...

Jennifer Stojkovic is pumped for Thanksgiving. As a new mom, she needs extra calories for recovery and breastfeeding — and the Super Bowl of Eating is the perfect excuse to load up. Stojkovic, who ...